388 related articles for article (PubMed ID: 28290973)
1. Total Artificial Heart Implantation as a Bridge to Heart Transplantation in an Active Duty Service Member With Amyloid Cardiomyopathy.
Scully MS; Wessman DE; McKee JM; Francisco GM; Nayak KR; Kobashigawa JA
Mil Med; 2017 Mar; 182(3):e1858-e1860. PubMed ID: 28290973
[TBL] [Abstract][Full Text] [Related]
2. Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis.
Gray Gilstrap L; Niehaus E; Malhotra R; Ton VK; Watts J; Seldin DC; Madsen JC; Semigran MJ
J Heart Lung Transplant; 2014 Feb; 33(2):149-56. PubMed ID: 24200511
[TBL] [Abstract][Full Text] [Related]
3. Natural history and therapy of AL cardiac amyloidosis.
Grogan M; Dispenzieri A
Heart Fail Rev; 2015 Mar; 20(2):155-62. PubMed ID: 25447844
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.
Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG
Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181
[TBL] [Abstract][Full Text] [Related]
5. Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure.
Maurer MS; Raina A; Hesdorffer C; Bijou R; Colombo P; Deng M; Drusin R; Haythe J; Horn E; Lee SH; Marboe C; Naka Y; Schulman L; Scully B; Shapiro P; Prager K; Radhakrishnan J; Restaino S; Mancini D
Transplantation; 2007 Mar; 83(5):539-45. PubMed ID: 17353770
[TBL] [Abstract][Full Text] [Related]
6. [The rapid progress of heart failure due to systemic amyloidosis with cardiac involvement--case report].
Gilowski W; Stryjewski P; Gilowska M; Liszniański P; Nowak J
Przegl Lek; 2015; 72(11):697-700. PubMed ID: 27012134
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of right ventricular systolic function in cardiac amyloidosis.
Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T
Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Chemotherapy for Light-Chain Amyloidosis in Patients Presenting With Symptomatic Heart Failure.
Sperry BW; Ikram A; Hachamovitch R; Valent J; Vranian MN; Phelan D; Hanna M
J Am Coll Cardiol; 2016 Jun; 67(25):2941-8. PubMed ID: 27339491
[TBL] [Abstract][Full Text] [Related]
9. Light chain amyloidosis 2012: a new era.
Gatt ME; Palladini G
Br J Haematol; 2013 Mar; 160(5):582-98. PubMed ID: 23294331
[TBL] [Abstract][Full Text] [Related]
10. Heart transplantation in cardiac amyloidosis.
Sousa M; Monohan G; Rajagopalan N; Grigorian A; Guglin M
Heart Fail Rev; 2017 May; 22(3):317-327. PubMed ID: 28281017
[TBL] [Abstract][Full Text] [Related]
11. [Heart transplantation and follow-up treatment with AL-amyloidosis in 5 patients].
Adam Z; Ozábalová E; Němec P; Bedáňová H; Kuman M; Krejčí J; Špinarová L; Žampachová V; Čermáková Z; Pour L; Krejčí M; Sanecká V; Štork M; Pika T; Straub J; Adamová D; Stavařová Y; Král Z; Mayer J
Vnitr Lek; 2018; 64(4):441-449. PubMed ID: 29791180
[TBL] [Abstract][Full Text] [Related]
12. Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management.
Estep JD; Bhimaraj A; Cordero-Reyes AM; Bruckner B; Loebe M; Torre-Amione G
Methodist Debakey Cardiovasc J; 2012; 8(3):8-16. PubMed ID: 23227279
[TBL] [Abstract][Full Text] [Related]
13. [The importance of cardiac bio-marker assay for the stratification and monitoring of AL amyloidosis patients - single center experience].
Pika T; Lochman P; Vymětal J; Metelka R; Flodr P; Minařík J; Látalová P; Zapletalová J; Bačovský J; Sčudla V
Vnitr Lek; 2013 Sep; 59(9):776-81. PubMed ID: 24073949
[TBL] [Abstract][Full Text] [Related]
14. Successful heart transplantation following melphalan plus dexamethasone therapy in systemic AL amyloidosis.
Mignot A; Bridoux F; Thierry A; Varnous S; Pujo M; Delcourt A; Gombert JM; Goujon JM; Favreau F; Touchard G; Herpin D; Jaccard A
Haematologica; 2008 Mar; 93(3):e32-5. PubMed ID: 18310532
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2014 Dec; 89(12):1132-40. PubMed ID: 25407896
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation.
Barrett CD; Alexander KM; Zhao H; Haddad F; Cheng P; Liao R; Wheeler MT; Liedtke M; Schrier S; Arai S; Weisshaar D; Witteles RM
JACC Heart Fail; 2020 Jun; 8(6):461-468. PubMed ID: 32387068
[TBL] [Abstract][Full Text] [Related]
17. Double organ transplantation in cardiac amyloidosis.
Gkouziouta A; Farmakis D; Manginas A; Sfyrakis P; Saroglou G; Adamopoulos S; Iliodromitis EK
J Cardiovasc Med (Hagerstown); 2016 Feb; 17(2):126-9. PubMed ID: 25333376
[TBL] [Abstract][Full Text] [Related]
18. A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis.
Kreusser MM; Volz MJ; Knop B; Ehlermann P; Schmack B; Ruhparwar A; Hegenbart U; Schönland SO; Katus HA; Raake PW
Clin Res Cardiol; 2020 Jun; 109(6):700-713. PubMed ID: 31630214
[TBL] [Abstract][Full Text] [Related]
19. Changes in cardiac biomarkers with bortezomib treatment in patients with advanced cardiac amyloidosis.
Hussain AS; Hari P; Brazauskas R; Arce-Lara C; Pasquini M; Hamadani M; D'Souza A
Am J Hematol; 2015 Nov; 90(11):E212-3. PubMed ID: 26284951
[No Abstract] [Full Text] [Related]
20. [Current treatment of AL amyloidosis].
Desport E; Moumas E; Abraham J; Delbès S; Lacotte-Thierry L; Touchard G; Fermand JP; Bridoux F; Jaccard A
Nephrol Ther; 2011 Nov; 7(6):467-73. PubMed ID: 21497573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
